Bildkälla: Stockfoto

Saniona: Second Tesomet Phase IIb study Underway - Redeye

Redeye views the initiation of the Phase IIb study in Tesomet for Prader-Willi Syndrome (PWS) as another significant milestone for the company and we give an initial comment.

Redeye views the initiation of the Phase IIb study in Tesomet for Prader-Willi Syndrome (PWS) as another significant milestone for the company and we give an initial comment.
Börsvärldens nyhetsbrev
ANNONSER